EDIT vs. VUG

Last updated Jun 4, 2026

EDIT (Editas Medicine, Inc.) is a stock, while VUG (Vanguard Growth ETF) is Large Cap Growth Equities fund tracking the CRSP US Large Cap Growth Index. Over the past 10 years, EDIT returned -22.08%/yr vs 18.26%/yr for VUG. At a 0.41 correlation, their price movements are largely independent.

Performance

EDIT vs. VUG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Editas Medicine, Inc. (EDIT) and Vanguard Growth ETF (VUG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, EDIT achieves a 35.61% return, which is significantly higher than VUG's 9.49% return. Over the past 10 years, EDIT has underperformed VUG with an annualized return of -22.08%, while VUG has yielded a comparatively higher 18.26% annualized return.

EDIT

• 1D: -1.42%
• 1M: -7.33%
• YTD: 35.61%
• 6M: 17.55%
• 1Y: 52.75%
• 3Y*: -34.00%
• 5Y*: -39.28%
• 10Y*: -22.08%

VUG

• 1D: -1.23%
• 1M: 6.22%
• YTD: 9.49%
• 6M: 8.72%
• 1Y: 27.84%
• 3Y*: 25.93%
• 5Y*: 15.11%
• 10Y*: 18.26%

*Multi-year figures are annualized to reflect compound growth (CAGR)

EDIT vs. VUG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
EDIT Editas Medicine, Inc.	35.61%	61.42%	-87.46%	14.21%	-66.59%	-62.13%	136.78%	30.15%	-25.97%	89.34%
VUG Vanguard Growth ETF	9.49%	19.40%	32.69%	46.83%	-33.16%	27.35%	40.25%	37.03%	-3.32%	27.72%

Correlation

The correlation between EDIT and VUG is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.28
Correlation (3Y) Calculated over the trailing 3-year period	0.29
Correlation (5Y) Calculated over the trailing 5-year period	0.40
Correlation (10Y) Calculated over the trailing 10-year period	0.41
Correlation (All Time) Calculated using the full available price history since Feb 4, 2016	0.41

The correlation between EDIT and VUG shifts across timeframes, from 0.28 (1 year) to 0.41 (10 years), reflecting how their relationship changes across market environments.

Return for Risk

EDIT vs. VUG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EDIT

EDIT Risk / Return Rank: 61
EDIT Sharpe Ratio Rank: 60
EDIT Sortino Ratio Rank: 65
EDIT Omega Ratio Rank: 62
EDIT Calmar Ratio Rank: 59
EDIT Martin Ratio Rank: 57

VUG

VUG Risk / Return Rank: 43
VUG Sharpe Ratio Rank: 50
VUG Sortino Ratio Rank: 47
VUG Omega Ratio Rank: 48
VUG Calmar Ratio Rank: 33
VUG Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EDIT vs. VUG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and Vanguard Growth ETF (VUG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	EDIT	VUG	Difference
Sharpe ratio Return per unit of total volatility	0.56	1.77	-1.20
Sortino ratio Return per unit of downside risk	1.50	2.40	-0.90
Omega ratio Gain probability vs. loss probability	1.17	1.31	-0.14
Calmar ratio Return relative to maximum drawdown	0.89	1.69	-0.81
Martin ratio Return relative to average drawdown	1.58	5.92	-4.34
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

EDIT vs. VUG - Sharpe Ratio Comparison

The current EDIT Sharpe Ratio is 0.56, which is lower than the VUG Sharpe Ratio of 1.77. The chart below compares the historical Sharpe Ratios of EDIT and VUG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	EDIT	VUG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.56	1.77	-1.20
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.42	0.68	-1.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.26	0.85	-1.12
Sharpe Ratio (All Time) Calculated using the full available price history	-0.20	0.62	-0.81

Drawdowns

EDIT vs. VUG - Drawdown Comparison

The maximum EDIT drawdown since its inception was -98.92%, which is greater than VUG's maximum drawdown of -50.68%. Use the drawdown chart below to compare losses from any high point for EDIT and VUG.

Drawdown Indicators

	EDIT	VUG	Difference
Max Drawdown Largest peak-to-trough decline	-98.92%	-50.68%	-48.24%
Max Drawdown (1Y) Largest decline over 1 year	-59.88%	-16.53%	-43.35%
Max Drawdown (3Y) Largest decline over 3 years	-91.46%	-22.85%	-68.61%
Max Drawdown (5Y) Largest decline over 5 years	-98.66%	-35.61%	-63.05%
Max Drawdown (10Y) Largest decline over 10 years	-98.92%	-35.61%	-63.31%
Current Drawdown Current decline from peak	-96.93%	-1.51%	-95.42%
Average Drawdown Average peak-to-trough decline	-62.56%	-7.09%	-55.47%
Ulcer Index Depth and duration of drawdowns from previous peaks	33.47%	4.71%	+28.76%

Volatility

EDIT vs. VUG - Volatility Comparison

Editas Medicine, Inc. (EDIT) has a higher volatility of 30.18% compared to Vanguard Growth ETF (VUG) at 3.83%. This indicates that EDIT's price experiences larger fluctuations and is considered to be riskier than VUG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	EDIT	VUG	Difference
Volatility (1M) Calculated over the trailing 1-month period	30.18%	3.83%	+26.35%
Volatility (6M) Calculated over the trailing 6-month period	61.46%	12.11%	+49.35%
Volatility (1Y) Calculated over the trailing 1-year period	94.33%	15.84%	+78.49%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	93.99%	22.22%	+71.77%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	83.75%	21.44%	+62.31%

Dividends

EDIT vs. VUG - Dividend Comparison

EDIT has not paid dividends to shareholders, while VUG's dividend yield for the trailing twelve months is around 0.37%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EDIT Editas Medicine, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VUG Vanguard Growth ETF	0.37%	0.41%	0.47%	0.58%	0.70%	0.48%	0.66%	0.95%	1.32%	1.14%	1.39%	1.30%

Frequently Asked Questions

Can I hold both EDIT and VUG in my portfolio?

EDIT and VUG have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, EDIT or VUG?

EDIT has higher volatility (30.18%) compared to VUG (3.83%). In terms of maximum drawdown, EDIT dropped -98.92% vs VUG's -50.68%.

Which has better risk-adjusted returns?

VUG currently has the higher Sharpe Ratio (1.77 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.